Oppenheimer raised the firm’s price target on Astria Therapeutics (ATXS) to $28 from $26 and keeps an Outperform rating on the shares.

Astria Therapeutics, Inc. ( (ATXS)) has released its Q3 earnings. Here is a breakdown of the information Astria Therapeutics, Inc. presented to its investors. Astria Therapeutics, Inc. is a ...

Oppenheimer raised the firm’s price target on Astria Therapeutics (ATXS) to $28 from $26 and keeps an Outperform rating on the shares. The firm notes that on Wednesday afternoon, Astria ...

Astria, a blockchain project describing itself as the "first decentralized shared sequencing layer," has launched the main network for its alpha release. The project is among those aiming to ...

Discover creative and practical ways to repurpose fireplace ashes in your home and garden. Learn about safety precautions and ...

“We had another strong quarter of execution for both navenibart and STAR-0310,” said Jill C. Milne, Ph.D., Chief Executive Officer at Astria Therapeutics. “We are excited about the opportunity for ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

LONDON/VIENNA (Reuters) -Russia told Austria on Friday it will suspend gas deliveries via Ukraine on Saturday, in a development that signals a fast-approaching end of Moscow's last gas flows to ...

European natural gas prices rose for the second consecutive session, with traders fixated on near-term supply risks, from tensions in the Middle East to production outages in Norway. Benchmark Dut ...

Michael Bradshaw receives funding from the UK Energy Research Centre (UKERC) that is funded by the Engineering and Physical Sciences Research Council (EPSRC) and the Economic and Social Research ...